ROTHSCHILD INVESTMENT LLC /IL - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,230
-23.8%
40,084
-0.6%
0.10%
-22.4%
Q2 2023$1,615
+326.1%
40,327
+333.9%
0.13%
+306.1%
Q1 2023$379
+5.6%
9,2940.0%0.03%0.0%
Q4 2022$359
-99.9%
9,294
+0.7%
0.03%
-32.7%
Q3 2022$491,000
-8.9%
9,2310.0%0.05%
-2.0%
Q2 2022$539,000
-22.1%
9,231
+1.9%
0.05%
-7.4%
Q1 2022$692,000
+28.9%
9,057
+1.5%
0.05%
+28.6%
Q4 2021$537,000
+7.4%
8,9230.0%0.04%0.0%
Q3 2021$500,000
-7.7%
8,923
-0.1%
0.04%
-2.3%
Q2 2021$542,000
-15.7%
8,933
-2.7%
0.04%
-21.8%
Q1 2021$643,000
+31.2%
9,181
+12.1%
0.06%
+17.0%
Q4 2020$490,000
-9.4%
8,190
-9.0%
0.05%
-20.3%
Q3 2020$541,000
+27.9%
8,998
+11.7%
0.06%
+15.7%
Q2 2020$423,000
-51.2%
8,059
-68.8%
0.05%
-54.9%
Q1 2020$866,000
+189.6%
25,813
+290.6%
0.11%
+276.7%
Q4 2019$299,0006,6090.03%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders